View in EDS PDF Full Text

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.

Saved in:
Bibliographic Details
Title: A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
Authors: Tarpgaard LS; Department of Oncology, Odense University Hospital, Odense, Denmark. line.tarpgaard@rsyd.dk., Qvortrup C; Department of Oncology, Odense University Hospital, Odense, Denmark. camilla.qvortrup@rsyd.dk., Nygård SB; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. Sune.Boris.Nygaard@regionh.dk.; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Sune.Boris.Nygaard@regionh.dk., Nielsen SL; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. siln@sund.ku.dk., Andersen DR; Department of Oncology, Odense University Hospital, Odense, Denmark. diana.riise.andersen@rsyd.dk., Jensen NF; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. tfm434@alumni.ku.dk., Stenvang J; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. stenvang@sund.ku.dk., Detlefsen S; Department of Pathology, Odense University Hospital, Odense, Denmark. sonke.detlefsen@rsyd.dk., Brünner N; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. nbr@sund.ku.dk., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark. per.pfeiffer@rsyd.dk.
Source: BMC cancer [BMC Cancer] 2016 Feb 11; Vol. 16, pp. 91. Date of Electronic Publication: 2016 Feb 11.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26867764
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tarpgaard+LS%22">Tarpgaard LS</searchLink>; Department of Oncology, Odense University Hospital, Odense, Denmark. line.tarpgaard@rsyd.dk.<br /><searchLink fieldCode="AU" term="%22Qvortrup+C%22">Qvortrup C</searchLink>; Department of Oncology, Odense University Hospital, Odense, Denmark. camilla.qvortrup@rsyd.dk.<br /><searchLink fieldCode="AU" term="%22Nygård+SB%22">Nygård SB</searchLink>; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. Sune.Boris.Nygaard@regionh.dk.; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Sune.Boris.Nygaard@regionh.dk.<br /><searchLink fieldCode="AU" term="%22Nielsen+SL%22">Nielsen SL</searchLink>; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. siln@sund.ku.dk.<br /><searchLink fieldCode="AU" term="%22Andersen+DR%22">Andersen DR</searchLink>; Department of Oncology, Odense University Hospital, Odense, Denmark. diana.riise.andersen@rsyd.dk.<br /><searchLink fieldCode="AU" term="%22Jensen+NF%22">Jensen NF</searchLink>; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. tfm434@alumni.ku.dk.<br /><searchLink fieldCode="AU" term="%22Stenvang+J%22">Stenvang J</searchLink>; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. stenvang@sund.ku.dk.<br /><searchLink fieldCode="AU" term="%22Detlefsen+S%22">Detlefsen S</searchLink>; Department of Pathology, Odense University Hospital, Odense, Denmark. sonke.detlefsen@rsyd.dk.<br /><searchLink fieldCode="AU" term="%22Brünner+N%22">Brünner N</searchLink>; Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmark. nbr@sund.ku.dk.<br /><searchLink fieldCode="AU" term="%22Pfeiffer+P%22">Pfeiffer P</searchLink>; Department of Oncology, Odense University Hospital, Odense, Denmark. per.pfeiffer@rsyd.dk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2016 Feb 11; Vol. 16, pp. 91. <i>Date of Electronic Publication: </i>2016 Feb 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26867764
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-016-2124-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 91
    Titles:
      – TitleFull: A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tarpgaard LS
      – PersonEntity:
          Name:
            NameFull: Qvortrup C
      – PersonEntity:
          Name:
            NameFull: Nygård SB
      – PersonEntity:
          Name:
            NameFull: Nielsen SL
      – PersonEntity:
          Name:
            NameFull: Andersen DR
      – PersonEntity:
          Name:
            NameFull: Jensen NF
      – PersonEntity:
          Name:
            NameFull: Stenvang J
      – PersonEntity:
          Name:
            NameFull: Detlefsen S
      – PersonEntity:
          Name:
            NameFull: Brünner N
      – PersonEntity:
          Name:
            NameFull: Pfeiffer P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 02
              Text: 2016 Feb 11
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1